M4ALL

January 28, 2021

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

M4ALL Announces New Synthesis for Molnupiravir for COVID-19 https://www.thearcadygroup.com/wp-content/uploads/2021/01/science-in-hd-OdEB1LNUidc-unsplash-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2021/01/science-in-hd-OdEB1LNUidc-unsplash-scaled.jpg January 28, 2021 January 25, 2021

May 21, 2020

M4ALL Selected as Key Partner for Major BARDA Grant

M4ALL Selected as Key Partner for Major BARDA Grant https://www.thearcadygroup.com/wp-content/uploads/2020/05/Copy-of-Untitled-3.png 940 788 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/05/Copy-of-Untitled-3.png May 21, 2020 September 9, 2020

March 7, 2019

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MedicationAbstract_v1.jpg 2000 1500 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MedicationAbstract_v1.jpg March 7, 2019 September 9, 2020

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

M4ALL Selected as Key Partner for Major BARDA Grant

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.

Navigation

Latest Resources

Stay Connected

M4ALL

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

M4ALL Selected as Key Partner for Major BARDA Grant

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Accelerating the availability and uptake of life-saving technologies and medications for patients who need them most.

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.